APRA on Interim Capital Treatment of Equity Investment in Subsidiaries
APRA issued a letter to all authorized deposit-taking institutions to advise of an interim change to the capital treatment of new or additional equity investments in banking and insurance subsidiaries. The planned finalization and implementation of the prudential standard APS 111 on "Capital Adequacy: Measurement of Capital" are now likely to be in 2021 and 2022, respectively; however, it is important that any new or additional equity investments made before then are undertaken with the proposed policy in mind. In the interim period, authorized deposit-taking institutions will be expected to notify APRA ahead of any new or additional equity investments in banking and insurance subsidiaries, which would result in the aggregate value of any investment exceeding 10% of the Common Equity Tier (CET)1 capital of an authorized deposit-taking institution.
In October 2019, APRA had launched a consultation outlining planned revisions to the prudential standard APS 111. The most significant proposal in this set of revisions was an adjustment to the capital treatment of authorized deposit-taking institutions’ equity investments in banking and insurance subsidiaries. In the interim period, there will be no change to the capital treatment of any existing equity investments in the banking and insurance subsidiaries, with these exposures continued to be risk-weighted at 300% if listed or 400% if unlisted. However, until the new APS 111 is finalized and implemented, APRA will require any new or additional equity investments in banking and insurance subsidiaries, where the amount of that new or additional investments takes the aggregate value of the investment above 10% of an authorized deposit-taking institutions CET1 capital, to be fully funded by equity capital at the authorized deposit-taking institution parent company level.
This interim measure reflects the direction of the proposed APS 111, but does not impact existing investments. It also does not restrict or prohibit authorized deposit-taking institutions from making new investments or increasing their existing investments in banking and insurance subsidiaries in the period ahead. However, it will ensure that any new or additional equity investments, particularly where the aggregate value of the investment is large relative to the authorized deposit-taking institutions' CET1 capital, are backed by appropriate capital to reduce the risk to Australian depositors.
Related Links
Keywords: Asia Pacific, Australia, Banking, Insurance, APS 111, Capital Adequacy, Equity Investment, Basel, Regulatory Capital, APRA
Featured Experts
María Cañamero
Skilled market researcher; growth strategist; successful go-to-market campaign developer
Nicolas Degruson
Works with financial institutions, regulatory experts, business analysts, product managers, and software engineers to drive regulatory solutions across the globe.
Pierre-Etienne Chabanel
Brings expertise in technology and software solutions around banking regulation, whether deployed on-premises or in the cloud.
Related Articles
PRA to Elaborate on Approach to Transposition of CRD5 by Mid-December
PRA published a statement that explains when to expect further information on the PRA approach to transposing the Capital Requirements Directive (CRD5), including its approach to revisions to the definition of capital for Pillar 2A.
SRB Sets Out Work Program for 2021-2023
SRB published the work program for 2021-2023, setting out a roadmap to further operationalize the Single Resolution Fund and to achieve robust resolvability of banks under its remit over the next three years.
EIOPA Consults on KPIs on Sustainability for Non-Financial Reporting
EIOPA is consulting on the relevant ratios to be mandatorily disclosed by insurers and reinsurers falling within the scope of the Non-Financial Reporting Directive as well as on the methodologies to build these ratios.
HM Treasury Extends Consultation Dates for FRF and Solvency II Reviews
HM Treasury extended the consultation period on Phase II of the Future Regulatory Framework (FRF) Review, from January 19, 2021 to February 19, 2021.
GHOS Endorses Coordinated Approach to Mitigate COVID Risks for Banks
The Group of Central Bank Governors and Heads of Supervision (GHOS), the oversight body of BCBS, endorsed a coordinated approach to mitigate COVID-19 risks to the global banking system.
US Agencies Issue Statement on LIBOR Transition
US Agencies (FDIC, FED, and OCC) issued a joint statement encouraging banks to cease entering into new contracts that use USD LIBOR as a reference rate as soon as practicable and in any event by December 31, 2021, to facilitate an orderly LIBOR transition.
ECB Publishes Guide on Management of Climate and Environmental Risks
ECB finalized guidance on the way it expects banks to prudently manage and transparently disclose climate and other environmental risks under the current prudential rules.
BCBS Amends Capital Treatment of Non-Performing Loan Securitizations
BCBS published a technical amendment to the capital treatment of securitizations of non-performing loans by banks.
PRA Policy on Stressed VaR and RNIV Calculations Under Market Risk
PRA published the policy statement PS23/20 on the calculation of stressed value at risk (sVAR) and risks not in value at risk (RNIV) under the market risk framework.
BoE to Move Statistical Data Collection to BEEDs Portal
BoE announced that the Data and Statistics Division is planning to move collection of statistical data to the BoE Electronic Data Submission (BEEDS) portal.
